Laura Ridolfi
- Oncology top 2%
- Immunology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research
- Co-authors
- Ruggero RidolfiMichele GuidaAngela RiccobonSteinar AamdalJohan HanssonDavid M. BermanLars BastholtOmid Hamid
- Topics
- Immunotherapy and Immune Responses (38 papers)Cancer Immunotherapy and Biomarkers (33 papers)CAR-T cell therapy research (19 papers)
- Cited by
- OncologyImmunologyOphthalmology
- Partner nations
- ItalyUnited StatesIndia
In The Last Decade
Laura Ridolfi
64 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 74
- Oncology 1.2k
- Immunology 877
- Molecular Biology 463
- Pulmonary and Respiratory Medicine 309
- Cancer Research 110
Countries citing papers authored by Laura Ridolfi
This map shows the geographic impact of Laura Ridolfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Ridolfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Ridolfi more than expected).
Fields of papers citing papers by Laura Ridolfi
This network shows the impact of papers produced by Laura Ridolfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Ridolfi. The network helps show where Laura Ridolfi may publish in the future.
Co-authorship network of co-authors of Laura Ridolfi
This figure shows the co-authorship network connecting the top 25 collaborators of Laura Ridolfi. A scholar is included among the top collaborators of Laura Ridolfi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Ridolfi. Laura Ridolfi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 31 | |
| 3 | 3 | |
| 4 | 5 | |
| 5 | 19 | |
| 6 | 19 | |
| 7 | 24 | |
| 8 | 6 | |
| 9 | 24 | |
| 10 | GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancer. | 7 |
| 11 | 14 | |
| 12 | 27 | |
| 13 | 31 | |
| 14 | 54 | |
| 15 | 45 | |
| 16 | 15 | |
| 17 | 7 | |
| 18 | 100 | |
| 19 | 17 | |
| 20 | 20 |
About Laura Ridolfi
Laura Ridolfi is a scholar working on Immunology, Oncology and Transplantation, having authored 67 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (38 papers), Cancer Immunotherapy and Biomarkers (33 papers) and CAR-T cell therapy research (19 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (877 citations) and Ophthalmology (86 citations). Laura Ridolfi has collaborated with scholars based in Italy, United States and India. Frequent co-authors include Ruggero Ridolfi, Michele Guida, Angela Riccobon, Steinar Aamdal, Johan Hansson, David M. Berman, Lars Bastholt, Omid Hamid, David M. Hyams and Aviram Nissan. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.